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Contrary to the generally accepted principle that selective 
reduction of pyrimidines occurs art the ~5• 6 position, the partial 
hydrogenation of 2-hydroxypyrimidine (I) over Adams' catalyst in 
ethanol was shown to afford 3,6-dihydro-2-hydroxypyrimidine (II). 
Upon subsequent reduction 3,4,5,6-tetrahydro-2-hydroxypyrimidine 
(III) was obtained. 
In order to ascertain the structure of the dihydro compound 
structurally unambiguous 1-methyl-2-oxopyrimidine (IV) was 
subjected to the same partial hydrogenation. The NMR spectra of so 
obtained dihydro-1 -methyl-2-oxopyrimidine (V) and the cor-
responding tetrahydro derivative VI, in particular the chemical 
shifts of their methyl groups (n 7.08 and 7.06 resp.), complied 
with the requirements for a 3,6-dihydro compound. 
4-Hydroxypyrimidine (IX) did not react with hydrogen under 
the above mentioned conditions. However, very slow reduction to 
1,2,3,6-tetrahydro-4-hydroxypyrimidine . (X) occured with rhodium 
on carbon as catalyst. On the other h and rhodium on carbon was 
shown to be very active for reduction of 3-methyl-4-oxopyrimidine 
(XII) yielding 1,2,3,6-tetrahydro-3-methyl-4-hydroxypyrimidine 
(XIII) . In this series the isolation of dihydro derivatives failed. 
In spite of wtde investigations of amino-, hydroxy- and hydropy111midtnes, 
it was not easy to correlate the published data of the reduction-oxidation 
processes of these compoun "Is. The reduction of pyrimidines to the chemically 
very sensitive hydropyrimiriines could influence the structures of ribonucleic 
and desoxyribonucleic acids and consequently the biological and genetic 
courses. The present study of hydroderivatives of 2- and 4-hydroxypyrimidines 
was initiated with the hope that the results would :bring additional light into 
chemistry and metabolism of the h e terocyclic components of polynucleotides, 
particularly with regards to 2,4-dihydroxypyrimidine (uracil)*. 




R=H Ill R= H 
IV R= CHi VI R= CH3( 
* The substituted pyrimidines are named without regard to keto-enol tauto-
merism1 i.e. the nomenclature d9e~ not reflect the actual state of the molecule. 
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Tio our knowledge the data of electrochemical1, rpolarogra:phic2 and cata-
lytic3-6 reductions of halo-, hydroxy- and thio"'Pyrimidines indicate that prefe-
rentially the 85,6 position undergoes hydrogenation and other chemical 
reactions. Consequently, it could be expected that !the partial hydrogenation of 
2-hydroxypyrimidine (I) would give 5,6-dihydro-2-hydroxypyrimidine as sugge-
sted by Fox and Praag5 for the intermediate which was not isolated, but 
showed in UV an absorption band at 260 mµ. The results presented in this 
paper were not in accord with thek presumption and indicated an exceptional 
course of hydrogenation when performed in ethanol using platinum as 
catalyst. The pK values, listed in Table I, and the values given for the chemical 
shifts (NMR spectrum, Figure 1) refered ·towards 3,6- i0r 3,4-dihydro-2-hydroxy-
pyrimidine (II), having an absorption at 248 mµ, log E 3.368. 
TABLE I 
Compound I PKk C 10-3 M pKa C 10-3 M 
II 2.73 4.49 ll.22 4.66 
III 2.71 4.65 11.18 4.97 
Urea 11.25 4.76 
I 3.05 4.53 9.21 , 4.8 
(2.24)7 100 (9.17)7 10 
The pK-values of the dihydro derivative II corresponded to the value of 
urea as well as of 3,4,5,6-tetrahydro-2-hydroxypyrimidine (III) but not of 
2-hydroxypyrimidine, to which these values should be closer if a 5,6-dihydro 
structure would have been present. 
The NMR spectrum of dihydro derivative II (Figure 1) clearly showed 
the signals related to ABC2 pattern with tau values 3.8, 5.8 and 5.95. These 
three bands with relative intensities 1 :1 :2 were consistent with the protons 
in 4,5 and 6 positions of compound II. 
However, these experiments still left unanswered the question whether 
the hydrogenation of compound I takes the course of a "1,2" or a "1,4 
addition". Namely, the addition at 3 and 6 or at 3 and 4 positions gives 
the same hydropyrimidine. To clarify this point the hydrogenation procedure 
was applied to 1-methyl-2-oxopyrimidine (IV) because of its undoubtful arran-
gement of double bonds. The .partially hydrogenated compound IV showed 
the NMR spectrum with the same chemical shifts, relative intensities of 
signals and spin coupling constants for protons at 4,5 and 6 position as for 
3,6-dihydropyrimid!ine II (Taible II). Ln addition the chemical shifts of methyl 
TABLE II 
Results from NMR measurements 
Com- Chemical shift, -r Coupling canst. 
pound 4-H 5-H I 6-H CHs ]4 ,5 I J5,6 I ]4,6 
II 3.82(6) 5.08(6) 5.95(4) 8.0 3.5 1.8 
v 3.83(6) 5.08(4) 5.94(4) 7.08 8.0 3.5 1.8 
Figures in brackets denote the number of line of multiplets. 'Spin coupling constants, 
/ 1 are ~iven in c.p.s .. 
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groups of dihydro- V ('r 7.08) and 3,4,5,6-tetrahydropyrimidine VI (-r 7.06)8 were 
of the same magnitude and differed from that one shown in the NMR 
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Fig. 1. NMR spectrum of 3,li-dihydro-2-hydroxypyrimidine 
PPM 
Although there was thought to be little if any 3,4,5,6-tetrahydro-1-methyl-
2-hydr.oxypyrim~dine (VI) present as cootaminant, our r esults i1J1dicaited .that 
the reduction proceeded via 3,6-dihydro-1-methyl-2-hydroxypyrimidine (V). 
The alternative "l ,2 addition" at the ~3 • 4 posion is ruled out. 
The above cooclusioos are put to practical use by studying the course of 
hydrogenation of ur~cil (VII)9• Namely in this case the course of "1 ,4 addition'' 
could produce 5,6-dihydrouracil (VIII) as well as " 1,2 addition". 
0 .S- OH 
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Complete catalytic hydrogenation of II and IV yielded tetrahydroderiva-
tives III and VI, previously prepared from 4-thiouracil and its 1-methyl-
-derivative5 respectively. 
The procedure used for hydrogenation of 2-hydroxypyrimidines failed 
in tht case of 4-hydroxypyrimidines. In an attempt to prepare its hydroderi-
vatives unchanged starting material was obtained. However, a slow r eduction 
took place in the ·presence of catalytic amounts of rhodium on carbon. In such 
hydrogenation 4-hydroxypyriimidine (IX) was converted into 1,2,3,6-tetra-
hydro-2-hydroxypyrimidine (X). Dihydmderivative could not be isolated indi-
cating concurrent. reductions. Compound X, treated with 10 per cent hydro-
chloric acid or 5 iper cent sod1um hyd-roxide was degraded to B-alanine. With 
nitrous acid XI yielded l-nit11oso-l ,2,3,6-tetrahydro-4-hydroxypyrimidine (XI) . 
0 OH OH 
(:NR 50/oRh/C Cr ..!i!i91_ CNH N) ~ HOAc N) 
H NO 
IX R=H x R=H XI 
XII R=CHi XIII R=CHi 
The h ydrogenation of 3-methyl-4-oxopyrimidine (XII) over rhodium on 
carbon proceeded to 1,2,3,6-tetrahydro-3-m ethyl-4-hydroxypyrimidine (XIII) 
at a surprisingly rapid rate. This finding did not agree with the conclusion1 
stating that -N-CO-C = C- grouping as part of a ring could not be reduced 
catalytically. The hydrolytic treatment of compound XIII with acicr or base 
yielded B-'alanine, methylamine and formaldehyde, thus confirming at the 
same time the 3 position of the methyl group. · 
EXPERIMENTAL 
Melti>ng points, uncorrected, were taken on a Kofler hot stage. The UV spectra were measured in 95% ethanol on Perkin-Elmer model 137-UV spectrophotometer with automatic gain control. The IR-absorption bands were recorded, unless otherwise stated, in potassium bromide plates on a Perkin-Elmer infracord model 137 and reported in wavelengths followed by relative dntensi1ties in brackets. The pK's values were determined by potentiometric micro-titrations in water with 0.1 N solution of sodium hydroxide and 0.1 N solution of hydr-ochloric acid. The pH values were not corrected. The NMR spectra were taken at a frequency of 60 Mc/sec on a Varian Model A 60 high resolution spectrometer. Solutions (8-100/o) in deuterium oxide were used. The sweep was calibrated using the common modulation side-band method. Values given for the chemical shifts, i:, were in parts per milion, tetra-methylsilane taken as zero. 
2-Hydroxypyrimidine (I) 
2-Amino-pyrimidine (10 g., 0.105 mmole) treated with 10 N sodium hydroxide (100 ml.) was converted into 2-hydroxypyrimidine according to the procedure of Brown10• The procedure for isolation of the product was modified. The mixture was refluxed for 12 hours and then left in the refrigerator overnight. The crystals were separated, filtered off, washed with a small amount of anhydrous ethanol, and then dissolved in redistilled water (1 1.). 2-Hydroxypyrimidine was isolated after the solution was passed through a column of Amberlite IRC-50. Yield 7 g. (700/o). The compound was recrystallized from ethanol, colorless needles, m.p. 
l7~-180° ~Brown10 reported m.p. 178-180°, yield 6.60/o; Hunt etal.U m.p. 179-181°). 
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3,6-Dihydro-2-hydroxypyrimidine (II) 
To reduced Adams' catalyst (200 mg.) in ethanol (10 ml.) the solution of 
2-hydroxypyrimid~ne (960 mg., 10 mmole) in ethanol (60 ml.) was added. The mixture 
was shaken with hydrogen about 35 minutes until orie equivalent ·has been con-
sumed. The platinum was filtered off and the filtrate evaporated· to dryness undet 
reduced pressure. The residue crystallized upon standing, m.p. 145--'-'!48° (extended}. 
The crystallization from absolute ethanol yielded 610 mg. (620/o), m·.p. 152-15411 with 
softening at 120°. Further crystallization from : absolute ethanol gave the ·analytical 
sample as colorless prisms, m.p. 156-157° · · - · · · 
Anal. C4H 6N20 (98.10) calc'd.: C 48.97; H 6.17; N 28.560/o 
found: C 49.16 ; H 5.94;·· N 28.7SO/o 
UV spectrum: 1'Amax 203 m~l, Jog e 3.372; 248 m~l, log e 3.368; ),min 216.5 mp . 
log e 2.895. IR spectrum: 3.07(s), 3.23(m), 3.45(m), 6.0(s), 6.68(s), 6.92(m), 7.';.7(w), 7,7Z(s), 
8.15(w), 8.32(m), 8.72(m), 9.49(vw). 9.70(w), 10.22(vw), 10.86(vw), p.37(w) ,, ll.86(w); 
12.7(w) µ. · . 
The NMR spectrum with i; values and spin coupling constants, J, are repre-' 
sented in Figure 1 and Table II respectively. 
3,4,5,6-Tetrahydro-2-hydroxypyrimidine (III) 
a) by cyclization. - Following the procedure for the preparation .of 2-imida-
zolidone12 propylendiamine (2.0 g., 27 mmole) was heated with urea (1.6 g.) and 
water (0.8 ml.). The residue was sublimed at 120°/0.02 mm, yield 2.2 g. (800/o), m.p-. 
2_63-26.4°. The in.p. remained unchanged after crystallization from absolute ethanol. 
(Fox and Praag5 reported m.p. 258-259°; for the compound obtained by reduction 
of 4-thiouracil). 
b) by reduction. - 3,6-Dihydro-2-hydroxypyrimidine (30 mg., 0.3 mmole) in 
ethanol (7 ml.) was hydrogenated over platinum oxide (8 mg.) under the same con-
dition as described for compound II. Recrystallized from absolute ethanol, yield 
25 mg. (820/o), m.p. 263-264°, undepressed on admixture with the .s;:imple obtained 
by cyclization. IR spectra of both sample were superimpqsable. 
3,6-Dihydro-1-methyl-2-hydroxypyrimidine (V) 
1-Methyl-2-oxopyrimidine13 (110 mg., 1.0 mmole) in · ethanol (20 ml.) was hydro-
genated over Adams' catalyst (20 mg.). In the course of about 30 minutes one mole 
of hydrogen was absorbed. The colorless needles separated quantitatively. Recrystal-
lization from ethylacetate-hexane yielded 47 mg: (44.60/o), m.p. 108-114° (extended). 
Further crystallization gave a sample with m.p. 120-121°. For analysis ·it was 
sublimed at 60°/5 · 10-• mm. 
Anal C5H8N20 (112.13) calc'd.: C 53.55; H 7.19; N 24 . 990/o 
found: C 53.83.; H 7.01; N 24.810/o 
UV spectrum: AAmax 202 mtl, log e 3.695; 250 mµ, log · e "3.362_; · Amin 222.5 m~1., 
log e 2.983. IR spectrum: 3.05(m), '3.25(m), 3.4(m), 6.06(s), 6.65(s), 6.95(m), 7:2(m), 7.74(m) ,' 
7.97(m), 8.3(m), 9.15(m), 9.75(w). 11.3(w), 12.95(m), 13.3(m), 14.25(m) µ. __ · · 
3,4,5,6-Tetrahydro-1-methyl-2-hydroxypyrimidine (VI) 
1-Methyl-2-hydroxypyrimidine13 (110 mg., 1.0 mmole) fn ethanol (20 ·ml.) 
was hydrogenated over platinum oxide (40 mg.) until two molec;ular equivalents 
were consumed (about 75 minutes). The crystalline product separated _quantitatively. 
m.p. 88-90.5•l. For analysis it was recrystallized from ethe:r;-hexa~e . as- .colorless 
needles, m.p. 94-960 (Fox and Praag5 reported m .p. 86-89°). . . ,,_ . 
Anal. C5H10N20 (114.15) calc'd. : C 52.61; H 8.83; N 24.540/o ' 
found: C 52.50; H 8.66; N 24.78°/c• 
UV spectrum: Amax 194 mµ, log e 3.735. IR spectrum: 2.94(s), . 3:24(s), 3.39(s), 
6.04(s), 6.54(s), 6.85(s), 7.14(s), 7.42(m)
1 
7.62(s) 1 7.88(m)1 8.p_4(rrl.), 9.06(m), 9,34(m), 10.07(w), 
13.13(m) p.. 
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1,2,3,6-Tetrahydro-4-fi:ydroxypyrimidine (X) 
4-Hydroxypyrimidjne (200 mg., 2 mmole), prepared from 2-thiouracil according to 
the procedure of Brown1', was dissolved in anhydrous methanol (15 ml.) and 5 per 
cent rho~ium on carbon catalyst (100 mg.) was added. The mixture was shaken 
with hydrogen under pressure of 65 psi until the fluorescence of starting material 
disappeared (about 13 hours). The catalyst was filtered off and the filtrate eva-
pora ted to a crystallin~ residue, m.p. 83-88°. It was ·recrystallized from ethylacetate 
as colorless prisms, m.p. 88-90°, yield 164 mg. (820/o). Further recrystallization from 
ethylacetate and sublimation ait 110°110-3 mm afforded the analytically pure sample, 
rn.p. ~l-920. 
Anal. C4HsN20 (100.12) calc'd.: C 47.98; H 8.05; N 27.980/o 
found: C 47.66; H 8.14; N 27.830/o 
UV spectrum: Amax 204 mµ, log E 3.449. IR spectrum: 2.95(s), 3.15(s), 3.32(s). 
3.42(s), 3.5(m), 6.l(s), 6.75(s), 6.85(s), 7.12(s), 7.32(s), 7.52(w), 7.65(s), 8.15(m), 8.27(w), 
8.8~m), 8.95(w), 9.5(m), 9.9(s), 10.4(m), 11.05(s), 11.55(s), 12.l(m), 12.8(m), 13.5(w) µ. 
1,2,3,6-Tetrahydro-1-nitroso-4-hydroxypyrimidine (XI) 
To the solution of l,2;3,6-tetrahydro-4-hydroxypyrimidine (45 mg., o.45 mmole) in 
water (1 ml.) sodium nitrite (40 mg., 0.57 mmole) and acetic acid (0.1 ml.) were added. 
The mixture was left at room temperature for 2 hours, diluted with water and 
passed through a column of Amberlite IRC-50. The eluate was evaporated under 
reduced pressur~. The oily residue solidified after standing. It was extracted with 
methylenechloride. Evaporation of the extract .to dryness yielded 42 mg. (80%) of 
crystalline product, m.p. 93-95°. For analysis it was recrystallized from methylene-
chloride-hexane as colorless prisms, m.p. 95-96°. 
Anal. C4H7N30 2 (129.12) calc'd.: C 37.21; H 5.46; N 32.550/o 
found: C 37.48; H 5.18; N 32.710/o 
UV spectrum: Amax 230.5 mµ log E 3.937 and shoulder A 203.5 mµ, log E 3.635. 
IR spectrum: 3.l(m), 3.2(m), 3.45(w), 5.85(s), 6.0(s), 6.75(m), 6.85(m), 6.95(m), 7.05(s), 
7.2(m), 7,5(s), 7.55(s), 7.68~s), 7.8(s), 7.95(m), 8.25(s), 8.45(m), 8.7(s), 9.28(s), 9.48(w), 
9.75(m), 10.l(m), 10.75(w), 12.45(w), 12.95(s), 14.75(m) µ. 
Hydrolysis of 1,2,3,6-tefrahydro-4-hydroxypyrimidine 
a) with sodium hydroxide. - 1,2,3,6-Tetrahydro-4-hydroxypyrimidine (30 mg., 
0.3 mmole) in 5 per cent sodium hydroxide (2 ml.) was refluxed for 90 minutes in 
an inert atmosphere. Evolved ammonia was absorbed in 10 per cent hydrochloric 
acid and isolated as ammonium chloride. The mixture was acidified with 10 per 
cent hydrochloric acid (2 ml.) and evaporated to dryness under reduced pressure. 
The residue was recrystallized from ethanol-ether, yield 21 mg. (660/o), m.p. 120--121°, 
µndepressed on admixture with an authentic sample o·f ~-alanine hydrochloride. The 
IR spectra of both sample were superimposable. 
b) with hydrochloric acid. - 1,2,3,6-Tetrahydro-4-hydroxypyrimidine (30 mg., 
0.3 mmole) in 10 per cent hydrochloric acid (2 ml.) was refluxed for 1 hour. The 
mixture was evaporat~d to dryness. Ammonium chloride, one undefined by-product 
and ~-alanine separated by fractional crystallization from ethanol-ether. ~-Alanine 
hydrochloride (31 mg., 830/o), m.p. 119-1210 was isolated. 
1,2,3,6-Tetrahydro-l-methyl-4-hydroxypyrimidine (XIII) 
3-Methyl-4-oxopyrimidine13 (110 mg., 1 mmole) was hydrogenated over 5 per 
cent rhodium on earbon catalyst (55 mg.) iln ethanol (20 ml.) until two molecular 
equivalents of hydrogen were absorbed (2.5 hours). The colorless oil, which separated 
quantitatively, was di&tilled at 65°/5·10-4 mm. 
Anal. CsH10N20 (114.15) calc'd.: C 52.61; H 8.83; N 24.54°/o 
found: C 52.67; H 8.54; N 24.390/o 
. I~ spectrum (neat): 2.79(m), 2.94(m), 3.35(m), 6.13(s), 6.64(s), 7.12(m), 7.3(s), 7.73(s), 
8.l(m); ·8.64(w), 9.76(m), 10.04(m), 10.72(w), ll .54(m), 13.44(w) µ. 
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Hydrolysis of 1,2,3,6-tetrahydro-3-methyl-4-hydroxypyrimidine 
a) with sodium hydroxide. - 1,2,3,6-Tetrahydro-3-methyl-4-hydrox-ypyrimidine 
(40 mg., 0.35 mmole) was refluxed with a 5 per cent aqueous sodium hydroxide 
solution (3 ml.). The volatile material was collected in 10 per cent hydrochloric 
acid, isolated quantitatively and identified as methylamine hydrochloride, m.p. 
2260 (recrystallized from ethanol-hexane), undepressed with an authentic sample. 
IR spectra of both sample were superimposable. B-Alanine. hydrochloride (39 mg., 
910/o), m .p. 120-1210 was isolated and identified as described before. 
b) with hydrochloric acid. - Tetrahydropyrimidine XIII (38 mg., 0.33 mmole) 
was treated with 10 per cent hydrochloric acid (2 ml.) as described for comJ?ound X . 
Formaldehyde was isolated by means of dimedone (m.p. 1870). The excess of dimedone 
was extracted with chloroform and B-alanine hydrochloride was separated by fractio-
nal crystallization from absolute ethanol-ether. 
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IZVOD 
Hidropirimidini. II. Prilog poznavanju selektivnog hidriranja nekih 
hidroksipirimidina 
V. Skaric, B . Ga.Spert i D. Skaric 
Suprotno zakljucku da selektivna redukcija pirimidina nastupa kod ~
5 • 6 po-
zicije, parcijalno kataliticko hidriranje 2-hidroksipirimidina (I) u etanolu (Pt kao 
katalizator) daje 3,6-dihidro-2-hidroksipirimidin (II). Daljnje hidriranje tvari II 
pod istim uslovima vodi do 3,4,5,6-tetrahidro-2-hidroksipirimidina (III),.· 
Da bi se utvrdila struktura dihidro spoja parcijalno se hidrirao strukturno ne-
dvojbeni 1-metil-2-oksopirimidin (IV) . NMR spektar tako dobivenog dihidro-1-
-metil-2-oksopirimidi!na, kao i odgovarajuceg tetrahidro derivata, a posebno ke-
mijski pomaci njihovih metilnih skupina (n 7.08 odnosno 7.06) odgovaraju podacima 
za 3,6-dihidro spoj . 
4-Hidroksipirimidin (IX) pod navedenim uslovima nije moguce reducirati. 
Medutim, vrlo polagana redukcija do 1,2,3,6-tetrahidro-4-hidroksipirimidina (XJ 
slijedi pored rodija na ugljenu kao katalizatora. Rodij na ugljenu se pokazao kao 
vrlo aktivan kod redukcije 3-metil-4-oksopirimidina (XII). Takva redukcija daje 
1,2,3,6-tetrahidro-4-hidroksipirimidiin (XIII), sto se opet protivi tvrdnjama da 
sistem N-CO-C=C- nije moguce reducirati ako je dio jednog ciklickog sistema. 
Hidroliza tvari XIII daje B-alanin, metilamin i formaldehid sto potvrduje njenu 
strukturu sa metilnom skupinom u pozicij<i 3. 
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